Top Markets
#1 Pleasing Gold Pleasing Gold +1,049.11%
#2 PulseChain PulseChain +56.32%
#3 BOOK OF MEME BOOK OF MEME +44.98%
#4 DogBull DogBull +36.74%
#5 Ontology Gas Ontology Gas +25.60%
#6 Neiro Neiro +22.37%
#7 Nockchain Nockchain +19.40%
#8 Pump.fun Pump.fun +18.98%
#9 Unit Pump Unit Pump +18.98%
#10 rsERG rsERG +17.44%
Coin of the day
Pleasing Gold Pleasing Gold
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Faeth Therapeutics, Inc. Faeth Therapeutics, Inc.

Faeth Therapeutics, Inc.

FTH
Clasificación en acciones #26771
Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on... Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]
Precio por acción
$28.27
Última sincronización: 2026-08-11
Capitalización bursátil
$37.93M
Cambio (1 día)
-1.07%
Cambio (1 año)
255.09%
País
US
Comercio Faeth Therapeutics, Inc. (FTH)

Categoría

Healthcare
Ganancias de Faeth Therapeutics, Inc. (FTH)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Faeth Therapeutics, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Faeth Therapeutics, Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH